Translational Platform for Regenerative Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Department of Plastic and Reconstructive Surgery, Centre of Postgraduate Medical Education, Prof. W. Orlowski Memorial Hospital, Warsaw, Poland.
Wound Repair Regen. 2022 May;30(3):303-316. doi: 10.1111/wrr.13013.
The application of mesenchymal stem/stromal cells (MSC) in regenerative medicine offers hope for the effective treatment of incurable or difficult-to-heal diseases. However, it requires the development of unified protocols for both safe and efficient cell acquisition and clinical usage. The therapeutic effect of fat grafts (containing stem cells) in non-healing wounds has been discussed in previous studies, although the application requires local or general anaesthesia. The treatment of MSC derived from adipose tissue (ASC) could be a less invasive method, and efficient delivery could lead to more favourable outcomes, which should encourage clinicians to use such therapeutic approaches more frequently. Therefore, the aim of this study was to optimise the methods of ASC isolation, culture and administration while maintaining their high survival, proliferation and colonisation potential. The ASC were isolated by an enzymatic method and were characterised according to International Society for Cellular Therapy and International Federation for Adipose Therapeutics and Science guidelines. To assess the opportunity to obtain a sufficient number of cells for transplantation, long-term cell cultures in two oxygen concentrations (5% vs. 21%) were conducted. For these cultures, the population doubling time, the cumulative time for cell population doublings and the rate of cell senescence were estimated. In a developed and pre-defined protocol, ASC can be efficiently cultured at physiological oxygen concentrations (5%), which leads to faster proliferation and slower cell senescence. Subsequently, to select the optimal and minimally invasive methods of ASC transplantation, direct cell application with an irrigator or with skin dressings was analysed. Our results confirmed that both the presented methods of cell application allow for the safe delivery of isolated ASC into wounds without losing their vitality. Cells propagated in the described conditions and applied in non-invasive cell application (with an irrigation system and dressings) to treat chronic wounds can be a potential alternative or supplement to more invasive clinical approaches.
间充质干细胞(MSC)在再生医学中的应用为有效治疗无法治愈或难以治愈的疾病带来了希望。然而,这需要开发统一的协议,以确保细胞的安全获取和临床应用的高效性。以前的研究已经讨论了脂肪移植物(包含干细胞)在非愈合性伤口中的治疗效果,尽管这种应用需要局部或全身麻醉。来源于脂肪组织的 MSC 治疗可能是一种侵入性更小的方法,而有效的输送可能会导致更有利的结果,这应该鼓励临床医生更频繁地使用这种治疗方法。因此,本研究的目的是优化 ASC 的分离、培养和给药方法,同时保持其高存活、增殖和定植潜力。通过酶法分离 ASC,并根据国际细胞治疗学会和国际脂肪治疗与科学联合会的指南对其进行特征描述。为了评估获得足够数量细胞进行移植的机会,在两种氧浓度(5%与 21%)下进行了长期细胞培养。对于这些培养物,估计了细胞倍增时间、细胞倍增次数的累积时间和细胞衰老率。在已开发并预先定义的方案中,可以在生理氧浓度(5%)下有效地培养 ASC,从而实现更快的增殖和更慢的细胞衰老。随后,为了选择 ASC 移植的最佳和微创方法,分析了直接用灌洗器或皮肤敷料进行细胞应用的效果。我们的结果证实,两种细胞应用方法都能安全地将分离的 ASC 输送到伤口中,而不会损失其活力。在描述的条件下繁殖并以非侵入性细胞应用(灌洗系统和敷料)应用的细胞可作为更具侵入性的临床方法的潜在替代或补充。